Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

Anticipations for AbbVie's Immunology Division in the Fourth Quarter

09 Jan, 2026

Anticipations for AbbVie's Immunology Division in the Fourth Quarter - TradingView

09 Jan, 2026

The 2026 Income Stronghold: Reasons Big Pharma is the Safe Investment for the Upcoming Year

30 Dec, 2025

ABBV or AZN: Which Pharmaceutical Stock Represents a Superior Investment Opportunity at This Time? - TradingView

23 Dec, 2025

See More